COVID-19 vaccine may have boosted survival in advanced lung cancer patients
Lung cancer patients who received COVID-19 vaccination survived nearly twice as long as similar patients who did not get the vaccine, a new observational study shows.
Engineered T cells targeting solid tumors show promising results in early patient trial
The IMA203 treatment uses T cells engineered to target the PRAME peptide, which is almost exclusively produced by solid tumors and not...
Danish study finds link between tattoos and lymphoma and skin cancer risk
CANCER DIGEST – March 8, 2025 – When most people get a tattoo, their health concerns center almost entirely on cleanliness and risk of...
Melanoma drug reduces disfiguring surgery for basal cell cancer
A drug, already approved for treating superficial melanomas, injected into basal cell tumors reduces surgery and scarring
A topical combination therapy may prevent SCC, the second most common form of skin cancer
Image credit – Winston Salem Dermatology Center CANCER DIGEST – Jan. 11, 2025 – A small study has shown that a novel topical treatment...
Immunotherapy combination dramatically improves long-term survival for melanoma patients
CANCER DIGEST – Sept. 16, 2024 – Long-term data from an international trial of immunotherapy for advanced melanoma show longer overall...
